MedPath

NUVARING

NUVARING

Approved
DIN Number

02253186

Drug Class

Human

Market Date

Dec 2, 2004

Company
HC

organon canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02253186
AIG Number0250087001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN
Product Specifications
Dosage FormRing (Slow-Release)
Route of AdministrationVaginal
AHFS Classification68:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

ETHINYL ESTRADIOLActive
Strength: 2.6 MG
Monograph: ETHINYL ESTRADIOL
ETONOGESTRELActive
Strength: 11.4 MG
Monograph: ETONOGESTREL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.